WIRB-Copernicus Group Acquires Vigilare International

Nov 28, 2017
By Applied Clinical Trials Editors

WIRB Copernicus Group® announced its acquirement of Vigilare International, a provider of integrated, end-to-end pharmacovigilance and drug safety solutions for the biopharmaceutical and biotech industry. This new acquistion is a perfect fit for both companies as Vigilare compliments WCG's existing clinical research solutions and they plan to identify more opportunities to streamline clinical research operations.

Read the full release here.

native1_300x100
lorem ipsum